SAN MATEO, California, December 11 /PRNewswire/ --

- Seeks UK partners to target new vertical and geographic markets

We are advised by dotMobi that journalists and other readers should disregard the news release, "Third .mobi 'Premium Domain Name' Online Auction Shatters Existing Price Records," issued December 10th over PR Newswire, as the release was issued prematurely.

Vance Hedderel of dotMobi, +1-703-485-5563, vhedderel@mtld.mobi; or Danielle Siemon of A&R Edelman for dotMobi (US), +1-650-762-2947, danielle.siemon@edelman.com; or Sasha Manners of Edelman for dotMobi (Europe), +44-20-7344-1504, sasha.manners@edelman.com; or Kate Donahue of Sedo, Director of Marketing, +1-617-499-7260, kate@sedo.com

PITTSBURGH, December 11 /PRNewswire/ --

Panopto, Inc. announced today that its CourseCast lecture-capture technology-developed and first implemented at Carnegie Mellon University-is being made available to qualified academic institutions free of charge.

CourseCast's easy-to-deploy lecture-capture technology enables educators to capture, edit, index, archive and stream video and audio over the Internet. CourseCast gives students on-demand access to indexed lectures and course material, enabling them to experience or revisit entire lectures, or to focus on segments of their choice. CourseCast is easily deployed using standard PCs and peripherals, which substantially drives down the cost of lecture-capture deployment.

LONDON, December 11 /PRNewswire/ --

- There's 15,000 Holiday Euros for the European Quitter!

The search is on for the first European Smoke Free Quitter of the Year 2008 who will be awarded the title and holiday vouchers worth 15,000 Euros. Eleven countries are participating including the UK and they will all choose a representative who will win a trip to the Award ceremony in Amsterdam in September 2008. You can also nominate a health care professional that has helped smokers quit and a public figure that has made an impact on smoking policy. To enter or nominate apply on line at http://www.quit.org.uk or ring Quitline 0800 002200

CALGARY, Canada, December 11 /PRNewswire/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced that it has been granted U.S. Patent 7,306,902 entitled "Oncolytic Viruses as Phenotyping Agents for Neoplasms." The claims describe methods of diagnosing cancers with unknown phenotypes by using oncolytic viruses that selectively replicate in cancer cells with known phenotypes.

"Oncolytic viruses are selective for certain mutations in cancer cells," said Dr. Matt Coffey, Chief Scientific Officer of Oncolytics. "By using these viruses in tumour samples, we may be able to more accurately diagnose the various cancer phenotypes, ultimately leading to a more individualized approach to cancer treatment."

About Oncolytics Biotech Inc.

CHICAGO, December 11 /PRNewswire/ --

- BREW Operator Creates India's First Full Mobile Internet Service

Novarra, the leader in mobile web gateway platforms and services, today announced that its Vision(TM) platform is powering Tata Indicom's market-leading full mobile internet service. The service is available on popular mass-market handsets such as the Motorola RAZR and the Samsung Explore.